Drugs / cinepazide

Trials 2 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01851759 Oct 2013 → Aug 2014 ischemic stroke Xijing Hospital Unknown No outcome recorded
Phase not applicable1 trial
NCT04951232 Jul 2016 → Jan 2017 ischemic stroke Peking University Third Hospital Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01831011 Comparator Jul 2008 → Apr 2010 ischemic stroke Xijing Hospital Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as cinepazide ClinicalTrials.gov intervention name — accepted as the source's own label NCT01851759
Known as Cinepazida ChEMBL registry synonym — accepted as the source's own label CHEMBL1874750
Known as Cinepazide Maleate ClinicalTrials.gov intervention name — accepted as the source's own label NCT04951232
1

NCT01831011

Known as MD 67350 FREE BASE ChEMBL registry synonym — accepted as the source's own label CHEMBL1874750
Known as Methanesulfonic acid cinepazide injection Methanesulfonic acid cinepazide injectionNCT01851759
Modality Small molecule CHEMBL1874750
Route Intravenous “iv gtt” NCT01851759